▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Rapid Medical™ Completes Successful Ischemic Stroke Procedures with the World’s First Robotic Thrombectomy Device

#AI--Rapid Medical™, a leading developer of advanced neurovascular devices, announces the first successful robotic thrombectomy in Medellín, Colombia. Two patients were treated with the Robotic TIG...

Business Wire

The procedures utilized an AI-powered, robotic TIGERTRIEVER to automate and optimize personalized treatments

YOKNEAM, Israel & DALLAS: #AI--Rapid Medical™, a leading developer of advanced neurovascular devices, announces the first successful robotic thrombectomy in Medellín, Colombia. Two patients were treated with the Robotic TIGERTRIEVER™, the first endovascular thrombectomy device that adapts autonomously to the patient’s anatomy.

“Automating stroke procedures is a significant advancement for the medical field,” emphasizes Dr. Boris Pabón, the endovascular neurosurgeon at Angiosur who performed the first-in-man procedures. “Robotic clot removal achieves a level of precision that surpasses interventional capabilities. The robotic TIGERTRIEVER gives me direct insight into the vessel characteristics and senses what I cannot–truly remarkable.”

With the press of a button, the AI-activated TIGERTRIEVER captures the blockage with active integration. The device’s radial force is then automatically reduced to minimize trauma to the brain as it is retrieved. This builds upon the excellent clinical results and procedure times seen with TIGERTRIEVER’s adjustability, further enhancing precision and streamlining workflow.

“Implementing this technology is a testament to our commitment to expanding treatment for stroke patients worldwide,” affirms Ronen Eckhouse, CEO of Rapid Medical. “We are at the forefront of advancing care—first by providing physicians with active technology and now paving a new pathway to automate procedures with intelligent control.”

About Rapid Medical

Rapid Medical expands what’s possible in neurovascular treatment by pioneering advanced interventional devices that treat ischemic and hemorrhagic stroke. Utilizing proprietary manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible. This enables physicians to respond in real time to the anatomy and tailor the approach to every patient for better procedural outcomes. TIGERTRIEVER™ 13, 17, and 21, COMANECI™ and COLUMBUS™/DRIVEWIRE are CE marked and FDA cleared. TIGERTRIEVER XL is also CE marked. More information is available at www.rapid-medical.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

25 Italian Startups Will Be Present at Expand North Star 2024

Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE

Partitalia: Italian IoT innovation in San Francisco

The Italian IoT company is in the US for the second phase of CALL4INNOVIT

Sparkle works on environmentally sustainable content distribution

The Italian company partners with MainStreaming for high-performance, energy-efficient video streaming

Libraesva: being specialized is ok again in cybersecurity

Software vendors developing vertical solutions against specific attack vectors are 'cool' again. And when it comes to email security, all companies now…

Most read

New Zealand Buy Now Pay Later Business and Investment Opportunities Databook…

The "New Zealand Buy Now Pay Later Business and Investment Opportunities Databook - Q2 2024 Update" report has been added to ResearchAndMarkets.com's…

Kenya Buy Now Pay Later Business Report 2024: BNPL Payments to Grow by…

The "Kenya Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis,…

Median Technologies to host two webcasts on September 5, 2024

Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.…

Mark Lawyer Joins RWS’s Executive Team as President of Regulated Industries…

RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces that Mark Lawyer has joined…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!